Keyphrases
Janus Kinase 2 (JAK2)
100%
Rheumatoid Arthritis
44%
Treatment Response
40%
Tofacitinib
40%
Janus Kinase Inhibitors
40%
Family Members
36%
JAK Inhibitors
33%
Myeloproliferative Neoplasms
29%
Isoform Selectivity
26%
Pseudokinase Domain
26%
JAK2 Inhibitor
25%
Pseudokinase
24%
Janus Kinase-signal Transducer
24%
Activators of Transcription Pathway
21%
Lymphopenia
20%
IRF2
20%
Soluble Biomarkers
20%
Resistance mutations
20%
New Scaffolds
20%
Binding Mechanism
20%
In Vitro Profiling
20%
Inflammation Diseases
20%
Nucleotide Binding
20%
Binding Protein
20%
Inhibitor Screening
20%
Activity Assay
20%
Rheumatic Diseases
20%
Erythropoietin Receptor
20%
Small Molecule Ligands
20%
Plasma Proteins
20%
Signaling Profile
20%
Inflammatory Conditions
20%
Drug Selectivity
20%
Functional Characterization
20%
Structural Characterization
20%
JAK2V617F
19%
Kinase Activity
12%
Erythropoietin
11%
Binding Mode
11%
Cytokine Inhibitors
10%
Peripheral Blood Mononuclear Cells
10%
Small Molecules
10%
Disease Activity Score 28 (DAS28)
8%
Conventional Synthetic Disease-modifying Antirheumatic Drugs
7%
T Cells
7%
Interleukin-6
6%
ATP-binding Pocket
6%
Therapeutic Approaches
6%
Momelotinib
6%
High Potency
6%
Pharmacology, Toxicology and Pharmaceutical Science
Janus Kinase
62%
Janus Kinase 2 Inhibitor
60%
Rheumatoid Arthritis
44%
Inflammatory Arthritis
44%
Tofacitinib
40%
Janus Kinase Inhibitor
33%
Cytokine
33%
Myeloproliferative Neoplasm
25%
Biological Marker
20%
Rheumatic Disease
20%
Inflammation
20%
Plasma Protein
20%
Janus Kinase 2
20%
Drug Selectivity
20%
Phosphotransferase
13%
Adenosine Triphosphate
10%
Erythropoietin
10%
Disease Modifying Antirheumatic Drug
7%
Interleukin 6
6%
Hematologic Disease
6%
Pacritinib
6%
Fedratinib
6%
Momelotinib
6%
Binding Site
6%
Ruxolitinib
6%
Biochemistry, Genetics and Molecular Biology
Janus Kinase 2
60%
Janus Kinase
40%
Adenosine Triphosphate
26%
Janus Kinase Inhibitor
26%
Isoform
23%
Cytokine
20%
Erythropoietin Receptor
20%
Drug Selectivity
20%
Enzyme
20%
Phosphotransferase
18%
Kinase
18%
Enzymatic Activity
12%
Binding Affinity
12%
Protein Kinases
10%
Kinome
10%
Evolution
10%
Erythropoietin
6%
